Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / GLPG - Takeda Pharmaceutical Vs. Gilead Sciences: Who Is The Dividend King?

GLPG - Takeda Pharmaceutical Vs. Gilead Sciences: Who Is The Dividend King?

Galapagos NV
  • Takeda's total debt was $35,698.6 million, down 22.1% from the previous year.
  • Takeda Pharmaceutical has a dividend yield of 5.15%, and Gilead Sciences has a dividend yield of 4.53%.
  • Gilead's key HIV drug is beginning to feel increased competition from ViiV Healthcare's drug.
  • Takeda management expects ENTYVIO sales to reach 659 billion yen in 2022, up 26% from 2021.
  • Sales of Trodelvy, which Gilead acquired for $21 billion in 2020, were $146 million in Q1 2022, up 23.7% from the previous quarter.

For further details see:

Takeda Pharmaceutical Vs. Gilead Sciences: Who Is The Dividend King?
Stock Information
Company Name: Galapagos NV
Stock Symbol: GLPG
Market: NASDAQ
Website: glpg.com
Menu
GLPG GLPG Quote GLPG Short GLPG News GLPG Articles GLPG Message Board
Get GLPG Alerts

News, Short Squeeze, Breakout and More Instantly...